Insider Purchases: Inside the Buy
Tag: Small Cap Stocks
🚀 Insperity (NSP): Why the CEO Just Bought Another $7.9M of This HR Stock
Insperity (NYSE: NSP) continues attracting major insider buying. CEO Paul Sarvadi has now purchased roughly $15.5 million of stock in less than three months, including a new $7.9 million purchase after shares rallied nearly 50%.
☕ Black Rock Coffee Bar (BRCB): The Hypergrowth Coffee Chain Wall Street May Have Oversold
Black Rock Coffee Bar (NASDAQ: BRCB) may be one of the market’s more fascinating small-cap growth stories hiding beneath a brutal selloff. With insider buying accelerating, revenue climbing nearly 24%, and profitability improving, investors are beginning to wonder whether Wall Street overshot the downside.
🥚 Vital Farms (VITL): The Great Egg Glut of 2026
Vital Farms stock has been absolutely scrambled by the 2026 egg glut, plunging more than 80% from its highs as profitability collapsed and short sellers flooded the farm. But coordinated insider buying, a debt-free balance sheet, and extreme institutional ownership suggest the setup may be far more explosive than the market currently realizes.
🚐 Patrick Industries Stock: Insider Buying, RV Rebound, and the Weekend Economy Play
Patrick Industries (PATK) is flashing a rare mix of insider conviction, institutional crowding, reasonable valuation, and cyclical risk. The setup looks promising — but patience may beat chasing.
Badger Meter (BMI) Stock Analysis 2026: Insider Buys After 24% Crash 💧📉
Badger Meter just took a 24% hit—but the CEO is buying the dip. With strong long-term water infrastructure trends and improved valuation, is BMI a hidden opportunity or just treading water?
$500K Insider Bet at 52-Week Lows: Is Shoe Carnival (SCVL) a Hidden Gem? 👟
Shoe Carnival (SCVL) is trading near lows with a $500K insider buy, high short interest, and ultra-cheap valuation. Is this a hidden value play—or a classic trap? 👟
🛢️ HMH Stock: Insiders Buy Millions After IPO Dip — Opportunity or Trap? 📉📈
HMH just IPO’d… and insiders are already buying millions. From strong margins to a pivot into mining and geothermal, here’s why this overlooked energy stock is getting attention.
Phreesia (PHR): Profitable… Then Crushed — Why Insiders Are Loading Up
Phreesia just hit profitability—and got punished for it. With insiders loading up and institutions fully committed, is this a classic overreaction or a value trap? Let’s decode the dip.
IPX Stock: America’s Titanium Comeback—or a Costly Experiment? 🦾
IperionX is betting on a U.S. titanium comeback. With government backing and disruptive tech, the upside is huge—but so are the risks.
2 comments
|
AbCellera (ABCL) Stock Analysis: 7 Triggers for a Biotech Short Squeeze or Long-Term Multibagger?
Down 95%, heavily shorted, yet sitting on $700M in liquidity and insider conviction — AbCellera (ABCL) may be biotech’s ultimate asymmetric bet.